These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
42. Response to Avoiding NICU Transfer for Newborns With Neonatal Opioid Withdrawal Syndrome (NOWS): A Quality Improvement Initiative to Manage NOWS on the Mother-baby Unit. Galvin SL; Ramage M J Addict Med; 2022 May-Jun 01; 16(3):371-372. PubMed ID: 34417411 [No Abstract] [Full Text] [Related]
43. Neonatal Opioid Withdrawal Syndrome Treatment Guidelines and Birth Hospital Utilization. Hahn PD; Graham DA; Ozonoff A; Milliren CE Pediatrics; 2024 Jul; 154(1):. PubMed ID: 38899388 [TBL] [Abstract][Full Text] [Related]
44. Demographics, Birth Parameters, and Social Determinants of Health Among Opioid-Exposed Mother-Infant Dyads Affected by Neonatal Abstinence Syndrome in Pennsylvania, 2018-2019. Decker CM; Mahar M; Howells CL; Ma ZQ; Goetz CT; Watkins SM Matern Child Health J; 2023 Dec; 27(Suppl 1):34-43. PubMed ID: 37243807 [TBL] [Abstract][Full Text] [Related]
45. The relationship between gestational age and the severity of neonatal abstinence syndrome. Gibson KS; Stark S; Kumar D; Bailit JL Addiction; 2017 Apr; 112(4):711-716. PubMed ID: 27886650 [TBL] [Abstract][Full Text] [Related]
46. Effect of Neonatal Abstinence Syndrome Treatment Status and Maternal Depressive Symptomatology on Maternal Reports of Infant Behaviors. Heller NA; Logan BA; Shrestha H; Morrison DG; Hayes MJ J Pediatr Psychol; 2023 Jul; 48(6):583-592. PubMed ID: 37159522 [TBL] [Abstract][Full Text] [Related]
47. Eat, Sleep, Console and Adjunctive Buprenorphine Improved Outcomes in Neonatal Opioid Withdrawal Syndrome. Hein S; Clouser B; Tamim MM; Lockett D; Brauer K; Cooper L Adv Neonatal Care; 2021 Feb; 21(1):41-48. PubMed ID: 33278102 [TBL] [Abstract][Full Text] [Related]
48. A protocol for enhancing the diagnostic accuracy and predictive validity of neonatal opioid withdrawal syndrome: The utility of non-invasive clinical markers. Maylott SE; Lester BM; Brown L; Castano AJ; Dansereau L; Crowell SE; Deboeck P; Salisbury A; Conradt E PLoS One; 2024; 19(9):e0306176. PubMed ID: 39255286 [TBL] [Abstract][Full Text] [Related]
49. Site-Level Variation in the Characteristics and Care of Infants With Neonatal Opioid Withdrawal. Young LW; Hu Z; Annett RD; Das A; Fuller JF; Higgins RD; Lester BM; Merhar SL; Simon AE; Ounpraseuth S; Smith PB; Crawford MM; Atz AM; Cottrell LE; Czynski AJ; Newman S; Paul DA; Sánchez PJ; Semmens EO; Smith MC; Turley CB; Whalen BL; Poindexter BB; Snowden JN; Devlin LA; Pediatrics; 2021 Jan; 147(1):. PubMed ID: 33386337 [TBL] [Abstract][Full Text] [Related]
50. The Negative Impact of Maternal Perinatal Opioid Use on Neonatal Outcomes. Gandhi KD; Schak KM; Vande JL; Shekunov J; Lynch BA; Rummans TA; Geske JR; Pease ER; Limbeck MG; Desai J; Croarkin PE; Romanowicz M Prim Care Companion CNS Disord; 2021 Jun; 23(3):. PubMed ID: 34115451 [No Abstract] [Full Text] [Related]
51. Sedatives for opioid withdrawal in newborn infants. Zankl A; Martin J; Davey JG; Osborn DA Cochrane Database Syst Rev; 2021 May; 5(5):CD002053. PubMed ID: 34002380 [TBL] [Abstract][Full Text] [Related]
52. Buprenorphine and Naloxone Versus Buprenorphine for Opioid Use Disorder in Pregnancy: A Cohort Study. Mullins N; Galvin SL; Ramage M; Gannon M; Lorenz K; Sager B; Coulson CC J Addict Med; 2020; 14(3):185-192. PubMed ID: 31567599 [TBL] [Abstract][Full Text] [Related]
53. Rooming-in care for infants of opioid-dependent mothers: Implementation and evaluation at a tertiary care hospital. Newman A; Davies GA; Dow K; Holmes B; Macdonald J; McKnight S; Newton L Can Fam Physician; 2015 Dec; 61(12):e555-61. PubMed ID: 27035006 [TBL] [Abstract][Full Text] [Related]
54. Evaluation of a Nurse-Led Program for Rural Pregnant Women With Opioid Use Disorder to Improve Maternal-Neonatal Outcomes. Paterno MT; Jablonski L; Klepacki A; Friedmann PD J Obstet Gynecol Neonatal Nurs; 2019 Sep; 48(5):495-506. PubMed ID: 31374181 [TBL] [Abstract][Full Text] [Related]
56. Prenatal opioid-exposed infant extracellular miRNA signature obtained at birth predicts severity of neonatal opioid withdrawal syndrome. Mahnke AH; Roberts MH; Leeman L; Ma X; Bakhireva LN; Miranda RC Sci Rep; 2022 Apr; 12(1):5941. PubMed ID: 35396369 [TBL] [Abstract][Full Text] [Related]
57. Maternal and iatrogenic neonatal opioid withdrawal syndrome: Differences and similarities in recognition, management, and consequences. Isaac L; van den Hoogen NJ; Habib S; Trang T J Neurosci Res; 2022 Jan; 100(1):373-395. PubMed ID: 33675100 [TBL] [Abstract][Full Text] [Related]
58. Within-Hospital Concordance of Opioid Exposure Diagnosis Coding in Mothers and Newborns. Clark RRS; French R; Lorch S; O'Rourke K; Rosenbaum KEF; Lake ET Hosp Pediatr; 2021 Aug; 11(8):825-833. PubMed ID: 34230061 [TBL] [Abstract][Full Text] [Related]